| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |